Following today's meeting with the FDA concerning IBT's live biotherapeutic product, IBT has decided to pursue an accelerated approval pathway for IBP-9414. The FDA's Accelerated Approval Program allo ...

Bacteria that produce many antibiotics use a surprising self-poisoning system to coordinate development. Sensing a key signal ...

New research suggests habitual nose picking could damage the nasal lining, allowing bacteria to enter the brain via the ...

A Swediah biopharma company developing live biotherapeutic products for diseases affecting premature infants, led by IBP-9414 ...

In several disease conditions, including infections and cancers, innate immune activation and nutrient scarcity occur ...

In A Nutshell Married people who feel emotionally supported by their spouse had BMIs about five points lower than married ...

People who recently purchased nasal spray from Walgreens are being warned that the product could be contaminated with a ...

Ehrlichia chaffeensis is an obligate intracellular bacterium responsible for human monocytic ehrlichiosis. Its pathogenesis hinges on the bacterium’s ability to invade mononuclear phagocytes and to ...

The microbiome in the vagina has received less attention than its cousin in the gut – but a well-balanced vaginal microbiome ...

Researchers uncover new indole metabolites from a blood bacterium that show remarkable anti-ageing properties, offering ...

Wockhardt's shares jumped 19.3% to ₹1,473 following the US FDA's acceptance of its antibiotic drug Zaynich's New Drug ...

African scientists have developed a nanoscale drug delivery system to treat pericarditis, a drug-resistant and lethal ...